Répertoire de l'Université Alfonso X el Sabio

Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study

Afficher la notice abrégée

APA

Brand, Randall E. & Persson, Jan & Bratlie, Svein Olav & Chung, Daniel C. & Katona, Bryson W. & Carrato, Alfredo & Castillo, María Encarnación & Earl, Julie & Kokkola, Arto & Lucas, Aimee L. & Moser, A. James & DeCicco, Corinne & Dexlin Mellby, Linda & King, Thomas C (2022-02 ) .Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.

ISO 690

Brand, Randall E. & Persson, Jan & Bratlie, Svein Olav & Chung, Daniel C. & Katona, Bryson W. & Carrato, Alfredo & Castillo, María Encarnación & Earl, Julie & Kokkola, Arto & Lucas, Aimee L. & Moser, A. James & DeCicco, Corinne & Dexlin Mellby, Linda & King, Thomas C. 2022-02 .Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.

https://hdl.handle.net/20.500.12080/39553
dc.contributor.author Brand, Randall E.
dc.contributor.author Persson, Jan
dc.contributor.author Bratlie, Svein Olav
dc.contributor.author Chung, Daniel C.
dc.contributor.author Katona, Bryson W.
dc.contributor.author Carrato, Alfredo
dc.contributor.author Castillo, María Encarnación
dc.contributor.author Earl, Julie
dc.contributor.author Kokkola, Arto
dc.contributor.author Lucas, Aimee L.
dc.contributor.author Moser, A. James
dc.contributor.author DeCicco, Corinne
dc.contributor.author Dexlin Mellby, Linda
dc.contributor.author King, Thomas C
dc.date.accessioned 2024-02-07T14:48:56Z
dc.date.available 2024-02-07T14:48:56Z
dc.date.created 2022-02
dc.date.issued 2022-02
dc.identifier.uri https://hdl.handle.net/20.500.12080/39553
dc.description.abstract The IMMray PanCan-d test combines an 8-plex biomarker signature with CA19-9 in a proprietary algorithm to detect pancreatic ductal adenocarcinoma (PDAC) in serum samples. This study aimed to validate the clinical performance of the IMMray PanCan-d test and to better understand test performance in Lewis-null (le/le) individuals who cannot express CA19-9. es_ES
dc.format application/pdf es_ES
dc.language eng es_ES
dc.rights CC-BY es_ES
dc.rights.uri http://creativecommons.org/licenses/by/4.0/deed.es es_ES
dc.title Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.rights.accessrights info:eu-repo/semantics/openAccess es_ES
dc.identifier.location N/A es_ES


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

CC-BY Excepté là où spécifié autrement, la license de ce document est décrite en tant que CC-BY

Chercher dans le dépôt


Parcourir

Mon compte

Social Media